Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

450

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

December 31, 2009

Conditions

Ovarian Cancer

Interventions

DRUG

Hycamtin

DRUG

Gemcitabine

Trial Locations (1)

Charité Campus Virchow-Klinikum, Berlin

All Listed Sponsors

lead

North Eastern German Society of Gynaecological Oncology

OTHER

NCT00312988 - Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | Biotech Hunter | Biotech Hunter